858 related articles for article (PubMed ID: 25892862)
1. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
2. Murine study of portal hypertension associated endothelin-1 hypo-response.
Theodorakis N; Maluccio M; Skill N
World J Gastroenterol; 2015 Apr; 21(16):4817-28. PubMed ID: 25944995
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
[TBL] [Abstract][Full Text] [Related]
4. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice.
Theodorakis NG; Wang YN; Skill NJ; Metz MA; Cahill PA; Redmond EM; Sitzmann JV
Gastroenterology; 2003 May; 124(5):1500-8. PubMed ID: 12730888
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
7. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
8. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
9. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
Zhao X; Deng B; Xu XY; Yang SJ; Zhang T; Song YJ; Liu XT; Wang YQ; Cai DY
World J Gastroenterol; 2013 Sep; 19(36):6069-76. PubMed ID: 24106408
[TBL] [Abstract][Full Text] [Related]
12. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage.
Hsieh JS; Wang JY; Lin SR; Lian ST; Chen FM; Hsieh MC; Huang TJ
J Surg Res; 2003 Nov; 115(1):24-32. PubMed ID: 14572769
[TBL] [Abstract][Full Text] [Related]
14. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension.
Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1074-81. PubMed ID: 12381520
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
16. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
Malyshev E; Tazi KA; Moreau R; Lebrec D
J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
[TBL] [Abstract][Full Text] [Related]
17. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
Du QH; Han L; Jiang JJ; Xu Y; Li WH; Li PT; Wang XY; Jia X
World J Gastroenterol; 2014 Nov; 20(44):16674-82. PubMed ID: 25469036
[TBL] [Abstract][Full Text] [Related]
18. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
Thabut D; Tazi KA; Bonnefont-Rousselot D; Aller M; Farges O; Guimont MC; Tellier Z; Guichard C; Ogier-Denis E; Poynard T; Moreau R; Lebrec D
Hepatology; 2007 Dec; 46(6):1893-906. PubMed ID: 17918268
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice.
Biecker E; Sägesser H; Reichen J
Eur J Clin Invest; 2004 Apr; 34(4):283-9. PubMed ID: 15086360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]